Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-04-25

FDA Approved: URSODIOL — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

The FDA approved a supplemental application for URSODIOL from BluePoint Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • URSODIOL (ursodiol)

Snippet

SUPPL AP for URSODIOL (URSODIOL)